Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Oramed Pharmaceuticals (ORMP) Return on Assets (2016 - 2026)

Oramed Pharmaceuticals filings provide 15 years of Return on Assets readings, the most recent being 0.0% for Q4 2025.

  • Quarterly Return on Assets changed 0.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Assets hit 0.0% in Q4 2025 for Oramed Pharmaceuticals, up from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q4 2025 and bottomed at 0.0% in Q2 2022.
  • Average Return on Assets over 5 years is 0.0%, with a median of 0.0% recorded in 2021.
  • Peak annual rise in Return on Assets hit 0bps in 2021, while the deepest fall reached 0bps in 2021.
  • Oramed Pharmaceuticals' Return on Assets stood at 0.0% in 2021, then plummeted by -75bps to 0.0% in 2022, then surged by 106bps to 0.0% in 2023, then crashed by -871bps to 0.0% in 2024, then surged by 367bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Return on Assets are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).